Moberg Pharma AB (publ) (STO:MOB)
Sweden
· Delayed Price · Currency is SEK 9.01
-0.09 (-1.04%)
At close: Dec 5, 2025
Moberg Pharma AB Balance Sheet
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Cash & Equivalents | 236.2 | 293.29 | 60.56 | 125.55 | 102.66 | 19.29 | Upgrade
|
| Cash & Short-Term Investments | 236.2 | 293.29 | 60.56 | 125.55 | 102.66 | 19.29 | Upgrade
|
| Cash Growth | -23.55% | 384.33% | -51.77% | 22.30% | 432.28% | -46.83% | Upgrade
|
| Accounts Receivable | 8.22 | 0.17 | - | 0.38 | 0.47 | - | Upgrade
|
| Other Receivables | - | 0.64 | 0.79 | 1.06 | 0.66 | 2.16 | Upgrade
|
| Receivables | 8.22 | 0.8 | 0.79 | 1.44 | 1.14 | 2.16 | Upgrade
|
| Inventory | 5.05 | 4.3 | 7.12 | - | - | - | Upgrade
|
| Prepaid Expenses | - | 1.58 | 0.9 | 0.72 | 0.75 | 0.85 | Upgrade
|
| Other Current Assets | - | 0.14 | 0.14 | 0.06 | 0.12 | 144.52 | Upgrade
|
| Total Current Assets | 249.46 | 300.11 | 69.49 | 127.76 | 104.66 | 166.81 | Upgrade
|
| Property, Plant & Equipment | 3.22 | 4.42 | 4.94 | 5.98 | 4.52 | 7.1 | Upgrade
|
| Long-Term Deferred Tax Assets | 98.38 | 95.78 | 28.08 | 22.58 | 14.67 | 10.93 | Upgrade
|
| Long-Term Deferred Charges | 342.6 | 305.77 | 532.22 | 408.1 | 327.04 | 295.73 | Upgrade
|
| Total Assets | 693.66 | 706.09 | 634.73 | 564.42 | 450.89 | 480.58 | Upgrade
|
| Accounts Payable | - | 4.16 | 6.77 | 17.11 | 5.31 | 2.95 | Upgrade
|
| Accrued Expenses | - | 10.67 | 12.5 | 7.56 | 7.45 | 8.73 | Upgrade
|
| Current Portion of Leases | 1.66 | 1.6 | 1.27 | 2.12 | 2.7 | 2.64 | Upgrade
|
| Other Current Liabilities | 13.8 | 0.29 | - | - | 0.09 | 65.87 | Upgrade
|
| Total Current Liabilities | 15.46 | 16.72 | 20.54 | 26.79 | 15.54 | 80.18 | Upgrade
|
| Long-Term Leases | 1.3 | 2.55 | 3.47 | 3.99 | 1.24 | 4.75 | Upgrade
|
| Other Long-Term Liabilities | - | - | - | 0.07 | 0.07 | 0.07 | Upgrade
|
| Total Liabilities | 16.75 | 19.27 | 24.01 | 30.84 | 16.84 | 85 | Upgrade
|
| Common Stock | 46.69 | 46.69 | 27.96 | 9.83 | 4.41 | 2.09 | Upgrade
|
| Additional Paid-In Capital | 1,238 | 1,234 | 921.3 | 841.2 | 731.38 | 693.28 | Upgrade
|
| Retained Earnings | -608.12 | -593.64 | -338.53 | -317.44 | -301.73 | -309.22 | Upgrade
|
| Comprehensive Income & Other | - | - | - | - | - | 1.73 | Upgrade
|
| Total Common Equity | 676.9 | 686.82 | 610.73 | 533.58 | 434.05 | 387.87 | Upgrade
|
| Minority Interest | - | - | - | - | - | 7.71 | Upgrade
|
| Shareholders' Equity | 676.9 | 686.82 | 610.73 | 533.58 | 434.05 | 395.58 | Upgrade
|
| Total Liabilities & Equity | 693.66 | 706.09 | 634.73 | 564.42 | 450.89 | 480.58 | Upgrade
|
| Total Debt | 2.95 | 4.14 | 4.74 | 6.11 | 3.93 | 7.4 | Upgrade
|
| Net Cash (Debt) | 233.24 | 289.15 | 55.82 | 119.45 | 98.72 | 11.89 | Upgrade
|
| Net Cash Growth | -23.60% | 418.02% | -53.27% | 20.99% | 730.24% | -47.89% | Upgrade
|
| Net Cash Per Share | 4.99 | 7.64 | 3.52 | 15.74 | 22.94 | 6.28 | Upgrade
|
| Filing Date Shares Outstanding | 47 | 46.69 | 27.96 | 9.83 | 4.4 | 1.99 | Upgrade
|
| Total Common Shares Outstanding | 47 | 46.69 | 27.96 | 9.83 | 4.4 | 1.99 | Upgrade
|
| Working Capital | 234.01 | 283.39 | 48.95 | 100.97 | 89.12 | 86.63 | Upgrade
|
| Book Value Per Share | 14.40 | 14.71 | 21.84 | 54.30 | 98.54 | 195.26 | Upgrade
|
| Tangible Book Value | 676.9 | 686.82 | 610.73 | 533.58 | 434.05 | 387.87 | Upgrade
|
| Tangible Book Value Per Share | 14.40 | 14.71 | 21.84 | 54.30 | 98.54 | 195.26 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.